June 11, 2020 / 11:57 PM / 22 days ago

BRIEF-Quidel Receives Barda Funding To Develop Point-Of-Care Diagnostic Assay That Includes COVID-19

June 11 (Reuters) - Quidel Corp:

* QUIDEL RECEIVES BARDA FUNDING TO DEVELOP POINT-OF-CARE DIAGNOSTIC ASSAY THAT INCLUDES COVID-19

* SOFIA® ASSAY WOULD TEST FOR FOUR VIRUSES IN 15 MINUTES OR LESS

* BARDA FUNDING WILL DIRECTLY SUPPORT QUIDEL’S DEVELOPMENT OF FOUR-VIRUS, POINT-OF-CARE TEST

* BARDA FUNDING BEGAN ON MAY 29, 2020, AND WILL RUN THROUGH APRIL 2021, TOTALING APPROXIMATELY $635,000 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below